On the other hand, it has been demonstrated that a combination of pomalidomide and low-dose dexamethasone can activate T cell function by increasing the release of interferon γ (IFN-γ), TNF-α, interleukin-2 (IL-2) derived from the T cells of relapsed/refractory MM patients. This evidence concerns the gene TNF and Miyoshi myopathy.